Stay updated on Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-08T13:35:48.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.
    Difference
    0.0%
    Check dated 2025-05-01T06:07:07.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-23T22:57:11.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed trial information and inclusion criteria for a clinical trial involving HuMax-AXL-ADC, while adding a new version number and identifiers related to the trial.
    Difference
    18%
    Check dated 2025-04-16T17:27:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T11:42:05.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.3%
    Check dated 2025-04-01T23:52:57.000Z thumbnail image

Stay in the know with updates to Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.